DeepMed Research

INXN-3001

Generic Name: INXN-3001

Clinical Trials

Clinical Trial to Evaluate the Safety and Immunogenicity of Synthetic DNAs Encoding NP-GT8 and IL-12, With or Without a TLR-agonist-Adjuvanted HIV Env Trimer 4571 Boost, in Adults Without HIV

Phase 1

Active, not recruiting

Conditions: HIV Infections

Interventions: Biological: sD-NP-GT8 DNA
Biological: IL-12 DNA
Biological: Trimer 4571
Biological: 3M-052-AF
Drug: Alum

First Posted Date: 2023-03-23

Last Posted Date: 2024-12-17

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 46

Registration Number: NCT05781542

Locations: 🇿🇦
Durban Adult HIV CRS, Durban, KwaZulu-Natal, South Africa
🇺🇸
Bridge HIV CRS, San Francisco, California, United States
🇿🇦
Soweto HVTN CRS, Johannesburg, Gauteng, South Africa

and more 5 locations

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy